EMS has proposed a merger with Hypera (HYPMY) in a deal that would create Brazil’s biggest pharmaceutical player, Pedro Arbex of Brazil Journal reports, citing people familiar with the matter. The transaction includes takeover bid would of R$30 per share, a premium of 17% compared to yesterday’s closing price and 39% to the current price, according to Arbex. A source involved in the operation told Brazil Journal that talks between the two companies about a potential merger have been going on for a long time.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Questions or Comments about the article? Write to editor@tipranks.com